Nektar Therapeutics (NKTR)Longaeva Partners L.P. exited its position 63K shares
Longaeva Partners L.P. exited its position in Nektar Therapeutics, per its Q4 2025 13F.
- 63K
- Prior-quarter shares · no longer reported
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Mar 12, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 21, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 8, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On May 7, 2026, the Company announced that Sandra Gardiner will be retiring and stepping down as interim Chief Financial Officer of the Company, effective May 15, 2026.”
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Nektar Therapeutics
For Nektar Therapeutics, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NKTR page.
How this filing works
Other disclosures at Nektar Therapeutics
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRNov 14, 2025
Everything OQRO holds on this company is on its NKTR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data